Table 2 Demographics and laboratory findings of COVID-19 patients

Gender(M/F), n/n

20/19

16/14

4/5

0.720

Age (years)^a

49 (31–56)

49 (25–55)

54 (47–75)

0.030

Current Smokers, n (%)

4 (10)

2 (7)

2 (22)

0.223

Diabetes History, n (%)

4 (10)

2 (7)

2 (22)

0.223

CVD History, n (%)

3 (8)

1 (3)

2 (22)

0.127

WBC(×10⁹/L)^a

6.27 (4.64–7.82)

5.70 (4.34–7.66)

6.42 (5.47–8.98)

0.243

Lymphcytes(×10⁹/L)^a

1.16 (0.84–1.68)

1.31 (1.02–1.78)

1.04 (0.59–1.16)

0.049

CRP (mg/L)^a

3.50 (0.50–16.50)

0.59 (0.50–5.06)

38.9 (17.3–66.6)

0.000

ESR (mm/h)^a

22.0 (12.0–39.5)

20.2 (10.6–29.4)

41.7 (27.0–76.8)

0.004

IL-6(pg/mL)^a

21.6 (12.0–30.8)

11.19 (7.45–15.54)

18.71 (17.20–32.52)

0.002

D-dimer (mg/L)^a

0.43 (0.19–0.88)

0.35 (0.15–0.52)

4.49 (1.29–7.00)

0.000

Lactic Acid (mmol/L)^a

0.88 (0.68–1.54)

0.80 (0.68–1.17)

1.95 (1.15–2.25)

0.004

SP-D (ng/mL)

292.9 ± 130.7

245.9 ± 90.0

449.7 ± 125.8

0.000

CT imaging score^a

9.0 (5.0–11.0)

9.0 (5.0–9.5)

10.0 (9.0–15.0)

0.011

Length of stay (days)

12.0 ± 4.3

10.6 ± 3.5

16.6 ± 3.5

0.000

DNA-N (days)^a

10.0 (6.0–14.0)

8.5 (5.0–11.8)

14.0 (11.0–17.0)

0.004